With one of the most anticipated media launches coming our way, how can brands cut through the noise, protect their budgets, ...
CG Life CEO David Ormesher and The Considered+AI founder Dave Hunt join MM+M to take listeners behind the curtain of the next ...
With Living Twice, Dentsu Creative Italy turns an iconic brand’s little-known history of organ transports into an emotional ...
With one of the most anticipated media launches coming our way, how can brands cut through the noise, protect their budgets, ...
MM+M Intelligence is an artificial intelligence assistant designed to help you navigate our comprehensive guide on medical ...
These Democrats would have to surmount political and legislative hurdles at a time when the realities of Medicaid expansion ...
The Fingerpaint founder is betting that sports can do more for healthcare marketers than put a pharmaceutical logo on a ...
Pharma has been rolling out lots of agentic AI pilots, but needs to incorporate the right metrics to move from speed to ...
As physicians increasingly turn to AI for answers, the OpenEvidence executive will unpack what happens when pharma's HCP ...
Oura’s telehealth acquisition muddies waters; Prostate cancer screening recommendations change for some men; Boston ...
Teva settles U.S. states' drug price-fixing case; FDA knocks potential Keytruda competitor; Johnson & Johnson acquires Ollin ...
The rule didn’t set a standard process for states to prove Native American status, allowing states to raise the threshold for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results